Advertisement

International Journal of Clinical Pharmacy

, Volume 35, Issue 1, pp 37–44 | Cite as

The effect of pharmacotherapeutic counseling on readmissions and emergency department visits

  • Srecko MarusicEmail author
  • Nives Gojo-Tomic
  • Viktorija Erdeljic
  • Vesna Bacic-Vrca
  • Miljenko Franic
  • Marijan Kirin
  • Velimir Bozikov
Research Article

Abstract

Objective To evaluate the impact of pharmacotherapeutic counseling on the rates and causes of 30-day post-discharge hospital readmissions and emergency department visits. Setting The study was conducted at the Medical Clinic of University Hospital Dubrava, Zagreb, Croatia. Methods The study included elderly patients prescribed with two or more medications for the treatment of chronic diseases. The patients randomized into the intervention group received pre-discharge counseling by the clinical pharmacologist about each prescribed medication. The control group received no counseling. Main outcome measures The rates and causes of 30-day postdischarge hospital readmissions and emergency department visits. Medication compliance was also evaluated, using the pill count method. Results A total of 160 patients were randomly selected for the study. No significant difference was found in the readmission and emergency department visit rates between the intervention and control groups (p = 0.224). There were 34.9 % more compliant patients in the intervention group. Significantly more non-compliant patients in the control group were readmitted or visited emergency department because of the disease progression (p = 0.031). In the intervention group, significantly more patients were readmitted or visited emergency department because of an adverse drug reaction (p = 0.022). Conclusion Pharmacotherapeutic counseling can reduce readmission and emergency department visit rates for disease progression. Improved patient knowledge about adverse drug reactions could be the reason for increased rates of readmissions and emergency department visits due to adverse drug reactions in the intervention group.

Keywords

Adverse drug reaction Compliance Croatia Emergency department visit Pharmacotherapeutic counseling Readmission 

Notes

Acknowledgments

We thank all patients for participating in the study.

Funding

The study received no external funding.

Conflicts of interest

None of the authors of this manuscript had any conflict of interests related to the study.

References

  1. 1.
    Prince BS, Goetz CM, Rihn TL, Olsky M. Drug-related emergency department visits and hospital admissions. Am J Hosp Pharm. 1992;49:1696–700.PubMedGoogle Scholar
  2. 2.
    Samoy LJ, Zed PJ, Wilbur K, Balen RM, Abu-Laban RB, Roberts M. Drug-related hospitalizations in a tertiary care internal medicine service of a Canadian hospital: a prospective study. Pharmacotherapy. 2006;26:1578–86.PubMedCrossRefGoogle Scholar
  3. 3.
    Davies EC, Green CF, Mottram DR, Rowe PH, Pirmohamed M. Emergency re-admissions to hospital due to adverse drug reactions within 1 year of the index admission. Br J Clin Pharmacol. 2010;70:749–55.PubMedCrossRefGoogle Scholar
  4. 4.
    Roughead EE. The nature and extent of drug-related hospitalisations in Australia. J Qual Clin Pract. 1999;19:19–22.PubMedCrossRefGoogle Scholar
  5. 5.
    Huic M, Mucolic V, Vrhovac B, Francetic I, Bakran I, Giljanovic S. Adverse drug reactions resulting in hospital admission. Int J Clin Pharmacol Ther. 1994;32:675–82.PubMedGoogle Scholar
  6. 6.
    Ernst FR, Grizzle AJ. Drug-related morbidity and mortality: updating the cost-of-illness model. J Am Pharm Assoc (Wash). 2001;41:192–9.Google Scholar
  7. 7.
    Somers A, Robays H, Vander Stichele R, Van Maele G, Bogaert M, Petrovic M. Contribution of drug related problems to hospital admission in the elderly. J Nutr Health Aging. 2010;14:477–82.PubMedCrossRefGoogle Scholar
  8. 8.
    Aminzadeh F, Dalziel WB. Older adults in the emergency department: a systematic review of patterns of use, adverse outcomes, and effectiveness of interventions. Ann Emerg Med. 2002;39:238–47.PubMedCrossRefGoogle Scholar
  9. 9.
    Kaufman DW, Kelly JP, Rosenberg L, Anderson TE, Mitchell AA. Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey. JAMA. 2002;287:337–44.PubMedCrossRefGoogle Scholar
  10. 10.
    Republic of Croatia—Central Bureau of Statistics. Women and men in Croatia. http://www.dzs.hr/Hrv_Eng/menandwomen/men_and_women_2009.pdf (2009). Cited 16 Jul 2012.
  11. 11.
    Republic of Croatia—Agency for medical products and medical devices. Annual report on drug consumption for 2010. http://www.almp.hr/?ln=en&w=publikacije&d=potrosnja_lijekova (2010). Cited 16 Jul 2012.
  12. 12.
    Al-Rashed SA, Wright DJ, Roebuck N, Sunter W, Chrystyn H. The value of inpatient pharmaceutical counselling to elderly patients prior to discharge. Br J Clin Pharmacol. 2002;54:657–64.PubMedCrossRefGoogle Scholar
  13. 13.
    Koehler BE, Richter KM, Youngblood L, Cohen BA, Prengler ID, Cheng D, et al. Reduction of 30-day postdischarge hospital readmission or emergency department (ED) visit rates in high-risk elderly medical patients through delivery of a targeted care bundle. J Hosp Med. 2009;4:211–8.PubMedCrossRefGoogle Scholar
  14. 14.
    Phillips DP, Christenfeld N, Glynn LM. Increase in US medication-error deaths between 1983 and 1993. Lancet. 1998;351:643–4.PubMedCrossRefGoogle Scholar
  15. 15.
    WHO, Regional Office for Europe. http://data.euro.who.int/hfadb/ (2012). Cited 16 Jul 2012.
  16. 16.
    Paulino EI, Bouvy ML, Gastelurrutia MA, Guerreiro M, Buurma H. Drug related problems identified by European community pharmacists in patients discharged from hospital. Pharm World Sci. 2004;26:353–60.PubMedGoogle Scholar
  17. 17.
    DiMatteo MR. Variations in patients’ adherence to medical recommendations: a quantitative review of 50 years of research. Med Care. 2004;42:200–9.PubMedCrossRefGoogle Scholar
  18. 18.
    Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353:487–97.PubMedCrossRefGoogle Scholar
  19. 19.
    Conn VS, Hafdahl AR, Cooper PS, Ruppar TM, Mehr DR, Russell CL. Interventions to improve medication adherence among older adults: meta-analysis of adherence outcomes among randomized controlled trials. Gerontologist. 2009;49:447–62.PubMedCrossRefGoogle Scholar
  20. 20.
    World Health Organization. Adherence to long-term therapies: evidence for action. http://www.who.int/chp/knowledge/publications/adherence_report/en/ (2003). Cited 16 Jul 2012.
  21. 21.
    McDonald HP, Garg AX, Haynes RB. Interventions to enhance patient adherence to medication prescriptions: scientific review. JAMA. 2002;288:2868–79.PubMedCrossRefGoogle Scholar
  22. 22.
    Herxheimer A. Many NSAID users who bleed don’t know when to stop. BMJ. 1998;316:492.PubMedCrossRefGoogle Scholar
  23. 23.
    Kerzman H, Baron-Epel O, Toren O. What do discharged patients know about their medication? Patient Educ Couns. 2005;56:276–82.PubMedCrossRefGoogle Scholar
  24. 24.
    Hughes L, Whittlesea C, Luscombe D. Patients’ knowledge and perceptions of the side-effects of OTC medication. J Clin Pharm Ther. 2002;27:243–8.PubMedCrossRefGoogle Scholar
  25. 25.
    Forster AJ, Murff HJ, Peterson JF, Gandhi TK, Bates DW. The incidence and severity of adverse events affecting patients after discharge from the hospital. Ann Intern Med. 2003;138:161–7.PubMedGoogle Scholar
  26. 26.
    Gurwitz JH, Field TS, Harrold LR, Rothschild J, Debellis K, Seger AC, et al. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA. 2003;289:1107–16.PubMedCrossRefGoogle Scholar
  27. 27.
    Schnipper JL, Kirwin JL, Cotugno MC, Wahlstrom SA, Brown BA, Tarvin E, et al. Role of pharmacist counseling in preventing adverse drug events after hospitalization. Arch Intern Med. 2006;166:565–71.PubMedCrossRefGoogle Scholar
  28. 28.
    Schulz KF, Altman DG, Moher D, CONSORT Group. CONSORT, statement: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:c332.PubMedCrossRefGoogle Scholar
  29. 29.
    Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239–45.PubMedCrossRefGoogle Scholar
  30. 30.
    Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management. Lancet. 2000;356:1255–9.PubMedCrossRefGoogle Scholar
  31. 31.
    Ponnusankar S, Surulivelrajan M, Anandamoorthy N, Suresh B. Assessment of impact of medication counseling on patients’ medication knowledge and compliance in an outpatient clinic in South India. Patient Educ Couns. 2004;54:55–60.PubMedCrossRefGoogle Scholar
  32. 32.
    Viktil KK, Blix HS, Moger TA, Reikvam A. Polypharmacy as commonly defined is an indicator of limited value in the assessment of drug-related problems. Br J Clin Pharmacol. 2007;63:187–95.PubMedCrossRefGoogle Scholar
  33. 33.
    Goodyer LI, Miskelly F, Milligan P. Does encouraging good compliance improve patients’ clinical condition in heart failure? Br J Clin Pract. 1995;49:173–6.PubMedGoogle Scholar
  34. 34.
    Rich MW, Gray DB, Beckham V, Wittenberg C, Luther P. Effect of a multidisciplinary intervention on medication compliance in elderly patients with congestive heart failure. Am J Med. 1996;101:270–6.PubMedCrossRefGoogle Scholar
  35. 35.
    Zolnierek KB, Dimatteo MR. Physician communication and patient adherence to treatment: a meta-analysis. Med Care. 2009;47:826–34.PubMedCrossRefGoogle Scholar
  36. 36.
    Krska J, Hansford D, Seymour DG, Farquharson J. Is hospital admission a sufficiently sensitive outcome measure for evaluating medication review services? A descriptive analysis of admissions within a randomised controlled trial. Int J Pharm Pract. 2007;15:85–91.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2012

Authors and Affiliations

  • Srecko Marusic
    • 1
    Email author
  • Nives Gojo-Tomic
    • 1
  • Viktorija Erdeljic
    • 2
  • Vesna Bacic-Vrca
    • 3
  • Miljenko Franic
    • 4
  • Marijan Kirin
    • 5
  • Velimir Bozikov
    • 6
  1. 1.Department of Clinical PharmacologyUniversity Hospital DubravaZagrebCroatia
  2. 2.Department of Clinical PharmacologyUniversity Hospital ZagrebZagrebCroatia
  3. 3.Department of Clinical PharmacyUniversity Hospital DubravaZagrebCroatia
  4. 4.Department of Orthopedic SurgeryUniversity Hospital DubravaZagrebCroatia
  5. 5.Intensive Care UnitUniversity Hospital DubravaZagrebCroatia
  6. 6.Department of EndocrinologyUniversity Hospital DubravaZagrebCroatia

Personalised recommendations